ModelEdge

Accentia Biopharmaceuticals Inc
0001310094
Filing Type10-K
Filing Date12/18/2011
Updated12/19/11, 10:15 AM

Filing

10-K
Earnings Release

Exhibits

10-KFORM 10-K
EX-10.57ROYALTY TERMINATION AGREEMENT
EX-10.58CLASS 4 PLAN PROMISSORY NOTE
EX-10.59STOCK PLEDGE AGREEMENT
EX-10.60ASSET PURCHASE AGREEMENT
EX-10.61AGREEMENT
EX-10.62LOAN SECURITY TERMINATION AGREEMENT
EX-10.63LOAN PREPAYMENT, MODIFICATION AND SECURITY TERMINATION AGREEMENT
EX-10.64AMENDED AND RESTATED SECURED TERM NOTE
EX-10.65AMENDED AND RESTATED SECURED TERM NOTE
EX-10.66AMENDED AND RESTATED SECURED TERM NOTE
EX-10.67AMENDED AND RESTATED SECURED TERM NOTE
EX-21SUBSIDIARIES OF ACCENTIA
EX-31.1CERTIFICATION
EX-31.2CERTIFICATION
EX-32.1CERTIFICATION
EX-32.2CERTIFICATION
EX-101.INSXBRL INSTANCE DOCUMENT
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
EXCELIDEA: XBRL DOCUMENT